JPH0225428A - Reduction of bitterness and bitterness reducing composition - Google Patents
Reduction of bitterness and bitterness reducing compositionInfo
- Publication number
- JPH0225428A JPH0225428A JP63172878A JP17287888A JPH0225428A JP H0225428 A JPH0225428 A JP H0225428A JP 63172878 A JP63172878 A JP 63172878A JP 17287888 A JP17287888 A JP 17287888A JP H0225428 A JPH0225428 A JP H0225428A
- Authority
- JP
- Japan
- Prior art keywords
- bitterness
- sodium sulfate
- substance
- bitter
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Grain Derivatives (AREA)
- General Preparation And Processing Of Foods (AREA)
- Jellies, Jams, And Syrups (AREA)
- Seasonings (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、苦味を有する物質に硫酸ナトリウムを添加し
た組成物および苦味を有する物質の苦味を軽減させる方
法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a composition in which sodium sulfate is added to a bitter substance and a method for reducing the bitterness of a bitter substance.
本発明の目的は、医薬品の薬効および食品の呈味を損な
わずに、苦味を選択的に軽減させる方法並びに苦味を有
する物質および硫酸ナトリウムを含有する苦味軽減組成
物を提供することにある。An object of the present invention is to provide a method for selectively reducing bitterness without impairing the medicinal efficacy of pharmaceuticals and the taste of foods, and a bitterness-reducing composition containing a bitter substance and sodium sulfate.
[従来の技術]
従来、医薬品および食品の分野において、苦味を有する
物質にいわゆる苦味マスク剤を添加して苦味を軽減させ
る方法か知られている。その方法としては、たとえば、
苦味を有する医薬品にウリジル酸またはシチジル酸およ
びそのナトリウム塩の単独または二種以上の混合物を添
加する方法(特公昭48−17044号)、苦味を有す
る医薬品または食品に構成アミノ酸が10個以下の1−
グルタミン酸含有ペプチドまたはし一アスパラギン酸含
有ペプチドを添加する方法(特開昭50−121449
号および同51−73113号)、苦味成分含有水性溶
液に、クエン酸およびクエン酸アルカリ金属塩を添加す
る方法(特開昭60−246325号)、塩化カリウム
の苦味を糖アルコールで軽減させる方法(時開す
昭62−32855 @)などが知られている。[Prior Art] Conventionally, in the fields of pharmaceuticals and foods, a method of reducing bitterness by adding a so-called bitterness masking agent to a substance having bitterness is known. For example,
A method of adding uridylic acid or cytidylic acid and a mixture of two or more of them to a bitter-tasting medicine (Japanese Patent Publication No. 17044/1983), a method of adding uridylic acid or cytidylic acid and a mixture of two or more thereof to a bitter-tasting medicine or food, and a method of adding one or more constituent amino acids to a bitter-tasting medicine or food. −
Method of adding glutamic acid-containing peptide or aspartic acid-containing peptide (JP-A-50-121449
No. 51-73113), a method of adding citric acid and an alkali metal citric salt to an aqueous solution containing a bitter component (Japanese Patent Application Laid-open No. 60-246325), a method of reducing the bitterness of potassium chloride with sugar alcohol ( Jikaisu 1986-32855 @) is known.
しかし、硫酸ナトリウムが、苦味を軽減する効果を有す
ることは、全く知られていない。However, it is completely unknown that sodium sulfate has the effect of reducing bitterness.
[発明が解決しようとする課題]
従来公知の苦味マスク剤によっては、たとえば、苦味を
有する食品の苦味を軽減させることかできても、呈味が
損なわれる場合があり、医薬品の薬効または食品の呈味
を損なわずに、苦味を選択的に軽減させる方法の開発が
望まれていた。[Problems to be Solved by the Invention] For example, although conventionally known bitterness masking agents can reduce the bitterness of bitter foods, they may impair the taste, which may impair the medicinal efficacy of pharmaceuticals or food products. It has been desired to develop a method for selectively reducing bitterness without impairing taste.
[課題を解決するための手段]
このような状況下において、本発明者らは苦味を有する
物質の苦味を軽減させる方法について、鋭意研究した結
果、硫酸ナトリウムが所期の目的を達成することを見出
し、本発明を完成するに至った。[Means for Solving the Problem] Under these circumstances, the inventors of the present invention have conducted extensive research into methods for reducing the bitterness of bitter substances, and have found that sodium sulfate can achieve the intended purpose. This discovery led to the completion of the present invention.
以下に本発明の詳細な説明する。The present invention will be explained in detail below.
本発明に用いられる苦味を有する物質としては、たとえ
ば、塩酸キニーネ、硫酸キニーネ、レシナミンおよびカ
フェインなど゛のアルカロイド;センブリ、ゲンチアナ
、ザボニンおよびタンニンなどの配糖体;エリスロマイ
シン、テ1〜ラザイクリン、タロラムフェニコールおよ
びセファレキシンなどの抗生物質;臭化水素酸デキスト
ロメトルファン、ヨウ化オキサピウム、塩酸メタロフエ
ノキザートおよび塩酸ヒドララジンなどの化学合成品;
Lトリプトファン、「−ロイシン、1−−メチオニンお
よびl−一リジンなどのアミノ酸またはそれらの塩酸塩
;シクランデレート;アミノピリン;塩化カリウムおよ
び硫酸マグネシウムなどの無機物質;リモネンなどのテ
ルペン:カセイン;大豆蛋白の分解物など並びにこれら
を含有する医薬品または食品が挙げられる。Examples of bitter substances used in the present invention include alkaloids such as quinine hydrochloride, quinine sulfate, rescinamine, and caffeine; glycosides such as Scutellaria japonica, gentian, zabonin, and tannin; Antibiotics such as ramphenicol and cephalexin; chemical synthetics such as dextromethorphan hydrobromide, oxapium iodide, metallofenoxate hydrochloride and hydralazine hydrochloride;
Amino acids or their hydrochlorides such as L-tryptophan, leucine, 1-methionine and l-lysine; cyclanderate; aminopyrine; inorganic substances such as potassium chloride and magnesium sulfate; terpenes such as limonene; casein; soy protein Examples include decomposition products of , as well as pharmaceuticals and foods containing these.
また、本発明において用いられる硫酸ナトリウムとして
は、たとえば、無水硫酸す1〜リウムおよび硫酸ナトリ
ウムの水和物、具体的には、硫酸ナトリウム・10水和
物などの水和物が挙げられる。Moreover, examples of the sodium sulfate used in the present invention include hydrates of anhydrous sodium sulfate and sodium sulfate, specifically hydrates such as sodium sulfate decahydrate.
また、苦味を有する物質に対する硫酸ナトリウムの添加
量は、通常、苦味を有する物質に対してo、 oooi
〜25倍(重量比)であり、たとえば、苦味を有する医
薬品の場合、対象医薬品の呈する苦味の強さによって異
なるが、対象医薬品の0.1倍(重量比)以上、好まし
くは、0.5〜25倍(重量比)であればよい。In addition, the amount of sodium sulfate added to a substance having a bitter taste is usually o, oooi for a substance having a bitter taste.
~25 times (weight ratio); for example, in the case of a bitter medicine, it varies depending on the intensity of bitterness exhibited by the target medicine, but it is 0.1 times or more (weight ratio) of the target medicine, preferably 0.5 It is sufficient if it is ~25 times (weight ratio).
また、苦味を有する食品の場合、対象食品が呈する苦味
の強さ、または、一部苦味を残存させる場合などによっ
て異なるが、対象食品のo、 oooi倍(重量比)以
上、好ましくは、固形状の対象食品に対しては0.00
05〜0.1倍(重量比)、液状の対象食品に対しては
o、 oooi〜0,1倍(重量比)である。In addition, in the case of a food with a bitter taste, it is preferable to use a solid powder that is at least o, oooi times (weight ratio) of the target food, although it depends on the strength of the bitterness exhibited by the target food or whether some bitterness remains. 0.00 for applicable foods.
0.05 to 0.1 times (weight ratio), and o,oooi to 0.1 times (weight ratio) for liquid target foods.
また、本発明方法に係る苦味を有する物質の性状は、固
形状、粉末状、液状などのいずれでもよい。Further, the substance having a bitter taste according to the method of the present invention may be in any form such as solid, powder, or liquid.
また、硫酸ナトリウムは、常法により、たとえば、粉末
状の医薬品または食品に対しては粉末の乾燥前または乾
燥後いずれの時期に添加してもよく、また、液状の医薬
品または食品に対しては、直接有効量を常法によって添
加すればよい。In addition, sodium sulfate may be added in a conventional manner, for example, to powdered pharmaceuticals or foods before or after drying the powder, or to liquid pharmaceuticals or foods. , may be directly added in an effective amount by a conventional method.
さらに、固形状の医薬品または食品に対しては成形前に
硫酸ナトリウムを混合させ、錠剤または顆粒とすればよ
く、ざらに、錠剤または顆粒の表面に硫酸ナトリウムを
含む皮膜を形成させてもよい。Furthermore, for solid pharmaceuticals or foods, sodium sulfate may be mixed before molding to form tablets or granules, or a film containing sodium sulfate may be formed on the surface of the tablets or granules.
[発明の効果]
1、苦味を有する医薬品に対する苦味の軽減効果パネラ
−により苦味を有する医薬品の水溶液または懸濁液1威
および苦味を有する医薬品に無水硫酸す1〜jノウムを
添加した水溶液または懸濁液1dをそれぞれ約5秒間、
口に含んで官能検査を行った。[Effects of the invention] 1. Effect of reducing bitterness on bitter-tasting pharmaceuticals Panelists have found that aqueous solutions or suspensions of bitter-tasting pharmaceuticals and aqueous solutions or suspensions of bitter-tasting pharmaceuticals with addition of sulfuric anhydride or 1 d of suspension for about 5 seconds each.
A sensory test was conducted by putting it in the mouth.
表中の各符号は下の意味を示す。Each symbol in the table indicates the meaning below.
全く苦味を感じない。I don't feel any bitterness at all.
± °はとんど苦味を感じない。± ° does not taste bitter at all.
十 ;弱い苦味を感じる。10: Feels a weak bitter taste.
+十;強い苦味を感じる。+10: I feel a strong bitterness.
+十十;極めて強い苦味を感じる。+10; Extremely strong bitterness.
苦味を有する医薬品に対して、無水硫酸す1〜リウムの
添加による苦味の軽減効果について、判定の結果を表−
1に示す。The table below shows the results of the evaluation of the effect of reducing the bitterness of bitter-tasting pharmaceuticals by adding sodium to lithium sulfate anhydride.
Shown in 1.
表−1
2,苦味を有する食品に対する苦味の軽減効果パネラ−
により苦味を有する食品および苦味を有する食品に無水
硫酸ナトリウムを添加した食品をそれぞれ口に含んで官
能検査を行った。Table 1 2.Bitterness reduction effect panel for bitter foods
A sensory test was conducted by holding a food with a bitter taste and a food with anhydrous sodium sulfate added to the bitter food in the mouth.
表中の各符号は下の意味を示す。Each symbol in the table indicates the meaning below.
;はとんど苦味を感じない。; I don't feel any bitterness at all.
+ ;弱い苦味を感じる。+; Feels a weak bitterness.
十十;強い苦味を感じる。10: I feel a strong bitter taste.
苦味を有プる食品に対して、無水硫酸す1〜リウムの添
加による苦味の軽減効果について、判定の結果を表−2
に示す。Table 2 shows the results of the evaluation of the bitterness reducing effect of adding sulfuric anhydride to bitter foods.
Shown below.
表−2 *]:ボに懸濁 *;パーセントは重量パーセントを示す。Table-2 *]: Suspended in Bo *; Percentage indicates weight percentage.
表−1および表−2の結果から明らかなように、硫酸ナ
トリウムは、苦味を有する物質の苦味を軽減させる効果
を有する。As is clear from the results in Tables 1 and 2, sodium sulfate has the effect of reducing the bitterness of bitter substances.
[実施例]
つぎに、本発明を実施例および製剤例を挙げて説明する
が、本発明はこれらに限定されるものではない。[Examples] Next, the present invention will be explained with reference to Examples and formulation examples, but the present invention is not limited thereto.
なあ、パーセントはすべて重量%である。Hey, all percentages are by weight.
また、実施例または製剤例において、メチルセルロース
、ポリビニルピロリドン、カルボキシメチルセルロース
・カルシウム塩および微結晶セルロースは、それぞれつ
ぎのものを使用した。In Examples and Formulation Examples, the following methylcellulose, polyvinylpyrrolidone, carboxymethylcellulose calcium salt, and microcrystalline cellulose were used, respectively.
○メチルセルロース(SR400:信越化学社製)○ポ
リビニルピロリドン(PVP −に30;バスフ社製)
○カルボキシメチルセルロース・カルシウム塩(ECG
505;ニチリン化学社製)○微結晶セルロース(ア
ビセルP旧01.旭化成社製)
実施例1
センブリ末100 m3を蒸留水100威に懸濁させ、
ついで、無水硫酸ナトリウム600#Igを添加し、セ
ンブリの0.1%懸濁液を得る。○Methylcellulose (SR400: manufactured by Shin-Etsu Chemical Co., Ltd.) ○Polyvinylpyrrolidone (PVP-30; manufactured by Basfu Corporation) ○Carboxymethylcellulose calcium salt (ECG
505; manufactured by Nichirin Kagaku Co., Ltd.) ○ Microcrystalline cellulose (Avicel P former 01. manufactured by Asahi Kasei Co., Ltd.) Example 1 100 m3 of assembly powder was suspended in 100 m3 of distilled water,
Then, 600 #Ig of anhydrous sodium sulfate is added to obtain a 0.1% suspension of the assembly.
実施例2
ヨウ化オキザピウム50m3を蒸留水100dに溶解さ
せ、ついで、無水5A酸ナトリウムeoomgを添加し
、ヨウ化オキザピウムの0.05%水溶液を得る。Example 2 50 m3 of oxapium iodide is dissolved in 100 d of distilled water, and then anhydrous sodium 5A acid eoomg is added to obtain a 0.05% aqueous solution of oxapium iodide.
実施例3
臭化水素酸デキストロメトルファン200mgを蒸留水
100威に溶解させ、ついで、無水硫酸ナトリウム60
0myを添加し、臭化水素酸デキストロメトルファンの
0.2%水溶液を得る。Example 3 200 mg of dextromethorphan hydrobromide was dissolved in 100 g of distilled water, and then 60 g of anhydrous sodium sulfate was dissolved in 100 g of distilled water.
0 my is added to obtain a 0.2% aqueous solution of dextromethorphan hydrobromide.
実施例4
L−1〜リプトフアン・塩酸塩1gを蒸留水100dに
溶解させ、ついで、無水硫酸ナトリウム600mgを添
加し、L−トリプトファン・塩酸塩の1%水溶液を得る
。Example 4 L-1 - 1 g of L-tryptophan hydrochloride is dissolved in 100 d of distilled water, and then 600 mg of anhydrous sodium sulfate is added to obtain a 1% aqueous solution of L-tryptophan hydrochloride.
実施例5
硫酸キニーネ25mgを蒸留水100m1に溶解させ、
ついて、無水硫酸ナトリウム600//iJを添加し、
硫酸キニーネの0.025%水溶液を得る。Example 5 25 mg of quinine sulfate was dissolved in 100 ml of distilled water,
Then, 600//iJ of anhydrous sodium sulfate was added,
A 0.025% aqueous solution of quinine sulfate is obtained.
実施例6
クロラムフェニコール50mgを蒸留水10(7に溶解
させ、ついで、無水硫酸ナトリウム19を添加し、クロ
ラムフェニコールの0.05%水溶液を得る。Example 6 50 mg of chloramphenicol is dissolved in 10 parts (7 parts) of distilled water, and then 19 parts of anhydrous sodium sulfate is added to obtain a 0.05% aqueous solution of chloramphenicol.
実施例7
グレープフルーツを半分に切り、果汁を絞り1個から約
260 mの果汁を得た。この果汁107を秤取し、無
水硫酸ナトリウム100#IJを添加して、グレープフ
ルーツ果汁を得る。Example 7 A grapefruit was cut in half and the juice was squeezed to obtain approximately 260 m of fruit juice from each grapefruit. This fruit juice 107 is weighed out and 100 #IJ of anhydrous sodium sulfate is added to obtain grapefruit juice.
実施例8
荒挽き]−ヒー末40gを熱湯400dで抽出し、抽出
液10dを秤取し、無水硫酸ナトリウム25mgを添加
して、コーヒー抽出液を得る。Example 8 Coarse grinding] - Extract 40 g of coffee powder with 400 d of hot water, weigh out 10 d of the extract, and add 25 mg of anhydrous sodium sulfate to obtain a coffee extract.
製剤例1.シロップ剤
臭化水素酸デキストロメトルファン1oomg、精製白
糖300rw)、クエン酸300mg、グリシン360
mg、無水FANすl〜ツリウム00/IIj9および
メチルセルロース300mgの粉末を蒸留水に溶解させ
、全体として100dになるように調製し、シロップ剤
を得る。Formulation example 1. Syrup Dextromethorphan hydrobromide 1oomg, refined white sugar 300rw), citric acid 300mg, glycine 360mg
Powders of 300 mg of anhydrous FANsu1~Thulium 00/IIj9 and methyl cellulose are dissolved in distilled water and adjusted to a total weight of 100 d to obtain a syrup.
製剤例29錠剤
ヨウ化オキサピウム10mg、乳糖30mg、トウモロ
コシデンプン80mg、微結晶セルロース5omgおよ
び無水硫酸ナトリウム(粉砕品)iomgをポリビニル
ピロリドン(10%水溶液) 5 mgを用いて練合し
、40℃で風乾する。これに、カルボキシメチルセルロ
ース・カルシウム塩20mgおよびステアリン酸マグネ
シウム5mgを加え、1錠当たり210mgに打錠し、
錠剤を得る。Formulation Example 29 Tablets 10 mg of oxapium iodide, 30 mg of lactose, 80 mg of corn starch, 5 omg of microcrystalline cellulose, and iomg of anhydrous sodium sulfate (pulverized product) were kneaded with 5 mg of polyvinylpyrrolidone (10% aqueous solution), and air-dried at 40°C. do. To this, 20 mg of carboxymethyl cellulose calcium salt and 5 mg of magnesium stearate were added, and each tablet was compressed to 210 mg.
Get the tablets.
製剤例3.生薬散剤(1日量)
ケイヒ末60mg、ニガキ末30mg、ショウキョウ末
30m1、ウィキョウ末30m3、オウバク末30m3
、カンゾウ末300m7、ソウジュラ末620mg、セ
ンブリ末50m3、乳糖900m7、微結晶セルロース
550m!Jおよび無水硫酸ナトリウム(粉砕品> 2
50 mgをポリビルピロリドン(10%エタノール溶
液) 150 mgを用いて練合し、40°Cで風乾す
る。ついで、32メツシユスクリーンを備えた整粒機で
整粒し、散剤を得る。Formulation example 3. Herbal medicine powder (daily dose): 60 mg of cinnamon powder, 30 mg of bittern powder, 30 m1 of ginger powder, 30 m3 of fennel powder, 30 m3 of powdered fenugreek
, 300m7 of licorice powder, 620mg of Sodula powder, 50m3 of Japanese sagebrush powder, 900m7 of lactose, 550m of microcrystalline cellulose! J and anhydrous sodium sulfate (pulverized product > 2
50 mg was mixed with 150 mg of polyvinylpyrrolidone (10% ethanol solution) and air-dried at 40°C. Then, the particles are sized using a sizing machine equipped with a 32-mesh screen to obtain a powder.
製剤例4.生薬散剤(1日量)
ケイヒ末80m1、ニガキ末30mg、ショウキョウ末
30m3、ウィキョウ末30mg、オウバク末30#I
9、カンゾウ末300771F、ンウジュツ末620#
lJ、センブリ末5omg、乳糖900my、微結晶セ
ルロース55h+gおよび硫酸ナトリウム・10水和物
(粉砕品) 570 m3をポリビニルピロリドン(1
0%エタノール溶液)150m!lを用いて練合し、4
0’Cで風乾する。ついで、32メツシユスクリーンを
備えた整粒機で整粒し、散剤を得る。Formulation example 4. Herbal medicine powder (daily dose): cinnamon powder 80ml, bittersweet powder 30mg, ginger powder 30m3, fennel powder 30mg, fenugreek powder 30#I
9. Licorice powder 300771F, licorice powder 620#
lJ, 5 omg of assembly powder, 900 my of lactose, 55 h+g of microcrystalline cellulose, and 570 m3 of sodium sulfate decahydrate (pulverized product) to polyvinylpyrrolidone (1
0% ethanol solution) 150m! Knead using 4
Air dry at 0'C. Then, the particles are sized using a sizing machine equipped with a 32-mesh screen to obtain a powder.
Claims (4)
とを特徴とする苦味を有する物質の苦味軽減方法。(1) A method for reducing the bitterness of a bitter substance, which comprises adding sodium sulfate to the bitter substance.
第(1)項記載の苦味を有する物質の苦味軽減方法。(2) The method for reducing the bitterness of a substance having a bitter taste according to claim (1), wherein the substance having a bitter taste is a pharmaceutical.
(1)項記載の苦味を有する物質の苦味軽減方法。(3) The method for reducing the bitterness of a substance having a bitter taste according to claim (1), wherein the substance having a bitter taste is a food.
ることからなる苦味軽減組成物。(4) A bitterness reducing composition comprising a bitter substance and sodium sulfate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63172878A JP2649175B2 (en) | 1988-07-12 | 1988-07-12 | Method of reducing bitterness and composition for reducing bitterness |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63172878A JP2649175B2 (en) | 1988-07-12 | 1988-07-12 | Method of reducing bitterness and composition for reducing bitterness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0225428A true JPH0225428A (en) | 1990-01-26 |
| JP2649175B2 JP2649175B2 (en) | 1997-09-03 |
Family
ID=15949983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63172878A Expired - Fee Related JP2649175B2 (en) | 1988-07-12 | 1988-07-12 | Method of reducing bitterness and composition for reducing bitterness |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2649175B2 (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202008006492U1 (en) | 2007-02-23 | 2008-08-21 | Basf Se | Use of water-dispersible carotenoid nanoparticles as taste modulators, flavor modulators containing water-dispersible carotenoid nanoparticles |
| DE202008006491U1 (en) | 2007-02-23 | 2008-08-21 | Basf Se | Use of azo compounds for taste modulation of compositions containing at least one high intensity sweetener (HIS) |
| WO2008102019A2 (en) | 2007-02-23 | 2008-08-28 | Basf Se | Use of water-dispersible carotinoid nanoparticles as taste modulators, taste modulators containing water-dispersible carotinoid nanoparticles, and method for taste modulation |
| DE202008006164U1 (en) | 2008-03-05 | 2008-10-02 | Basf Se | Use of a polyoxyethylene sorbitan fatty acid ester for taste modulation of compositions containing at least one High Intensity Sweetener (HIS) |
| DE202008006163U1 (en) | 2008-03-05 | 2008-10-02 | Basf Se | Use of a salt preparation for flavor modulation of compositions containing at least one High Intensity Sweetener (HIS) |
| CN102138900A (en) * | 2011-03-18 | 2011-08-03 | 海南灵康制药有限公司 | Solid preparation of oxapium iodide liposome |
| JP2013143935A (en) * | 2011-12-16 | 2013-07-25 | Okuno Chemical Industries Co Ltd | Taste improving method of alkaline inorganic salt, producing method of food additive, and food additive |
| US8809398B2 (en) | 2007-01-16 | 2014-08-19 | Basf Se | Liquid formulations containing a carotinoid |
| US9375387B2 (en) | 2008-10-07 | 2016-06-28 | Basf Se | Ready-to-use, stable emulsion |
| US11185093B2 (en) | 2007-11-29 | 2021-11-30 | Christian Köpsel | Pulverulent carotenoid preparation for colouring drinks |
-
1988
- 1988-07-12 JP JP63172878A patent/JP2649175B2/en not_active Expired - Fee Related
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8809398B2 (en) | 2007-01-16 | 2014-08-19 | Basf Se | Liquid formulations containing a carotinoid |
| DE202008006492U1 (en) | 2007-02-23 | 2008-08-21 | Basf Se | Use of water-dispersible carotenoid nanoparticles as taste modulators, flavor modulators containing water-dispersible carotenoid nanoparticles |
| DE202008006491U1 (en) | 2007-02-23 | 2008-08-21 | Basf Se | Use of azo compounds for taste modulation of compositions containing at least one high intensity sweetener (HIS) |
| WO2008102019A2 (en) | 2007-02-23 | 2008-08-28 | Basf Se | Use of water-dispersible carotinoid nanoparticles as taste modulators, taste modulators containing water-dispersible carotinoid nanoparticles, and method for taste modulation |
| WO2008102018A2 (en) | 2007-02-23 | 2008-08-28 | Basf Se | Method for modulating the taste of material compisitions containing at least one high intensity sweetener (his) |
| US11185093B2 (en) | 2007-11-29 | 2021-11-30 | Christian Köpsel | Pulverulent carotenoid preparation for colouring drinks |
| WO2009109226A1 (en) | 2008-03-05 | 2009-09-11 | Basf Se | Method for modulating the taste of material compositions containing at least one high intensity sweetener (his) |
| WO2009109227A1 (en) | 2008-03-05 | 2009-09-11 | Basf Se | Method for modulating the taste of material compositions containing at least one high intensity sweetener (his) |
| DE202008006163U1 (en) | 2008-03-05 | 2008-10-02 | Basf Se | Use of a salt preparation for flavor modulation of compositions containing at least one High Intensity Sweetener (HIS) |
| DE202008006164U1 (en) | 2008-03-05 | 2008-10-02 | Basf Se | Use of a polyoxyethylene sorbitan fatty acid ester for taste modulation of compositions containing at least one High Intensity Sweetener (HIS) |
| US9375387B2 (en) | 2008-10-07 | 2016-06-28 | Basf Se | Ready-to-use, stable emulsion |
| US10004670B2 (en) | 2008-10-07 | 2018-06-26 | Basf Se | Ready-to-use, stable emulsion |
| CN102138900A (en) * | 2011-03-18 | 2011-08-03 | 海南灵康制药有限公司 | Solid preparation of oxapium iodide liposome |
| JP2013143935A (en) * | 2011-12-16 | 2013-07-25 | Okuno Chemical Industries Co Ltd | Taste improving method of alkaline inorganic salt, producing method of food additive, and food additive |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2649175B2 (en) | 1997-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE60652B1 (en) | Spray dried ibuprofen | |
| JPH02164820A (en) | Ibuprofen-flavored masking method | |
| IE53543B1 (en) | New oral dipyridamole preparations | |
| CA2618977C (en) | Orally disintegratable tablet | |
| TW200522980A (en) | Drug-including particle and solid drug formulation comprising said particle | |
| CN101239044B (en) | Solid composition | |
| KR20150015500A (en) | Pharmaceutical composition of entecavir and process of manufacturing | |
| US20090176877A1 (en) | Oseltamivir phoshate granule and preparation method thereof | |
| JP2649175B2 (en) | Method of reducing bitterness and composition for reducing bitterness | |
| JP2007191419A (en) | Pimobendan oral dosage formulation | |
| TWI286072B (en) | Sleeping medicine formed by coating solid | |
| CN108904455B (en) | A method for preparing tablet containing high-dose oil ester component | |
| JP2005104844A (en) | Composition in which unpleasant smell or taste of cysteines is reduced | |
| JP4400941B2 (en) | Kampo-containing tablets, Kampo-filled capsules, herbal medicine-containing tablets, herbal medicine-filled capsules, manufacturing method of Kampo-containing tablets, herbal medicine-containing capsules, herbal medicine-containing tablets, and herbal medicine-filled capsules | |
| CN102258490B (en) | Ibuprofen chewable tablet | |
| JPH06100602A (en) | Solid oral preparation and production thereof | |
| CA1334933C (en) | Pharmaceutical composition and process for its preparation | |
| JPS63243034A (en) | Solid agent containing low-melting substance | |
| EA015349B1 (en) | Solid unit oral pharmaceutical dosage form of saquinavir mesylate and a process for making thereof | |
| JP2001294524A (en) | Oral solid preparation containing acetaminophen | |
| CN1042492C (en) | Preparing method for apovincamine acid ethyl ester | |
| JPH04327528A (en) | Oral solid preparation | |
| CN101239042A (en) | Oral solid composition with masked bitter taste | |
| JP3202775B2 (en) | Solid preparation | |
| JP4572296B2 (en) | Pimobendan oral dosage formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |